Literature DB >> 17907073

Neurobehavior of preterm infants at 36 weeks postconception as a function of morphine analgesia.

Rakesh Rao1, Jackie S Sampers, Shari S Kronsberg, Josephine V Brown, Nirmala S Desai, K J S Anand.   

Abstract

This study evaluated early neurobehavioral outcomes in ventilated preterm infants randomized to receive morphine analgesia or placebo in the Neurological Outcomes and Pre-emptive Analgesia in Neonates (NEOPAIN) trial. Eight hundred and ninety-eight infants between 23 and 32 weeks of gestation were randomized to receive preemptive morphine analgesia (morphine) or placebo. Infants also received additional analgesia (AA) with open-label morphine. The Neurobehavioral Assessment of the Preterm Infant (NAPI) was used to evaluate 572 of 793 survivors (72.1%) at 36 weeks of postconceptual age. The Neonatal Medical Index (NMI) was used to evaluate the severity of medical complications. Regression analyses were used to determine the effect of covariates. Infants were equally distributed in morphine and placebo groups with similar neonatal and demographic characteristics. Infants assessed with the NAPI were more likely to have sepsis ( P = 0.03), bronchopulmonary dysplasia ( P = 0.02), and longer length of stay ( P = 0.008). Infants randomized to the morphine group had higher NMI scores (odds ratio [OR]; 95% confidence interval [CI]: 1.75; 1.23 to 2.50; P = 0.002). Use of AA was associated with higher NMI scores (OR; 95% CI: 4.5; 2.9 to 5.9; P < 0.001). Of the NAPI subscales, the (mean +/- standard deviation [SD]) popliteal angle cluster scores were significantly higher in the morphine group compared with placebo (51.2 +/- 33.2 versus 45.0 +/- 33.5; P = 0.03). AA use was associated with lower (mean +/- SD) MOTOR scores in the morphine group (48.2 +/- 16.1 versus 52.7 +/- 19.1; P = 0.03) and with lower POPLITEAL ANGLE cluster scores in both the morphine group (41.5 +/- 34.0 versus 59.5 +/- 30.1; P < 0.0001) and the placebo group (40.8 +/- 36.8 versus 49.4 +/- 28.0; P = 0.004). No differences were noted in the other NAPI subscales cluster scores in either subgroup. We conclude that morphine analgesia may result in subtle neurobehavioral differences in premature infants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17907073     DOI: 10.1055/s-2007-986675

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  14 in total

1.  Long-term effects of neonatal stress on adult conditioned place preference (CPP) and hippocampal neurogenesis.

Authors:  Sarah L Hays; Ronald J McPherson; Sandra E Juul; Gerard Wallace; Abigail G Schindler; Charles Chavkin; Christine A Gleason
Journal:  Behav Brain Res       Date:  2011-10-28       Impact factor: 3.332

2.  Sedation and analgesia in mechanically ventilated preterm neonates: continue standard of care or experiment?

Authors:  Christopher McPherson
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10

3.  Adult responses to an ischemic stroke in a rat model of neonatal stress and morphine treatment.

Authors:  Sarah L Hays; Olga A Valieva; Ronald J McPherson; Sandra E Juul; Christine A Gleason
Journal:  Int J Dev Neurosci       Date:  2012-09-28       Impact factor: 2.457

Review 4.  Long-term impact of neonatal injury in male and female rats: Sex differences, mechanisms and clinical implications.

Authors:  Jamie L LaPrairie; Anne Z Murphy
Journal:  Front Neuroendocrinol       Date:  2010-02-06       Impact factor: 8.606

Review 5.  Neonatal pain control and neurologic effects of anesthetics and sedatives in preterm infants.

Authors:  Christopher McPherson; Ruth E Grunau
Journal:  Clin Perinatol       Date:  2013-12-17       Impact factor: 3.430

6.  Neonatal morphine exposure in very preterm infants-cerebral development and outcomes.

Authors:  Rachel Steinhorn; Christopher McPherson; Peter J Anderson; Jeffrey Neil; Lex W Doyle; Terrie Inder
Journal:  J Pediatr       Date:  2015-05       Impact factor: 4.406

7.  Renal impairment and hydronephrosis in a premature infant following morphine infusion: case report.

Authors:  Mohammad Khassawneh; Hassan Al-Balas
Journal:  Pediatr Nephrol       Date:  2008-05-15       Impact factor: 3.714

Review 8.  Pain management in newborns: from prevention to treatment.

Authors:  Elizabeth Walter-Nicolet; Daniel Annequin; Valerie Biran; Delphine Mitanchez; Barbara Tourniaire
Journal:  Paediatr Drugs       Date:  2010-12-01       Impact factor: 3.022

9.  Smaller Cerebellar Growth and Poorer Neurodevelopmental Outcomes in Very Preterm Infants Exposed to Neonatal Morphine.

Authors:  Jill G Zwicker; Steven P Miller; Ruth E Grunau; Vann Chau; Rollin Brant; Colin Studholme; Mengyuan Liu; Anne Synnes; Kenneth J Poskitt; Mikaela L Stiver; Emily W Y Tam
Journal:  J Pediatr       Date:  2016-01-04       Impact factor: 4.406

10.  Neonatal pain, parenting stress and interaction, in relation to cognitive and motor development at 8 and 18 months in preterm infants.

Authors:  Ruth E Grunau; Michael F Whitfield; Julianne Petrie-Thomas; Anne R Synnes; Ivan L Cepeda; Adi Keidar; Marilyn Rogers; Margot Mackay; Philippa Hubber-Richard; Debra Johannesen
Journal:  Pain       Date:  2009-05       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.